Finally, Zhang et al. propose a regulatory pathway in which tight junction protein 1 (TJP1) inhibits EGFR/JAK1/STAT3 signaling, possibly through a direct interaction between TJP1 and EGFR, in MM cells. The gene discussed is TJP1; the disease is Miyoshi myopathy.